Bleomycin Jet Injections in Keloids

Summary

This is a single center, double-blind (patient and investigator), randomized, placebo-controlled study with a split-lesion design, in which selected keloids will receive three consecutive treatments of a) bleomycin and b) placebo (saline (NaCl 0,9%)), administered with an electronic pneumatic jet injector.

Timeline

Start

2022-03-18

Primary completion

2022-11-18

Completion

2023-03-30

Drugs

Indications